Ligand Pharmaceuticals Incorporated (LGND) Company Report Aug. 09, 2022, 13:59 UTC 40 New SEC Form for Ligand Pharmaceuticals Incorporated Comment Full text
Viracta Therapeutics Inc (VIRX) Company Report Aug. 09, 2022, 13:51 UTC 41 New SEC Filing for (CIK:0001061027) Comment Full text
Viracta Therapeutics Inc (VIRX) Company Report Aug. 09, 2022, 13:50 UTC 43 New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX) Comment Full text
MannKind Corporation (MNKD) Company Report Aug. 09, 2022, 13:48 UTC 43 New Form 10-Q for MannKind Corporation Comment Full text
Neoleukin Therapeutics Inc. (NLTX) Company Report Aug. 09, 2022, 13:42 UTC 41 New Form 10-Q for Neoleukin Therapeutics, Inc. Comment Full text
Halozyme Therapeutics Inc. (HALO) Company Report Aug. 09, 2022, 13:03 UTC 38 Halozyme - Second Quarter 2022 Comment Full text
Avidity Biosciences Inc (RNA) Company Report Aug. 09, 2022, 10:35 UTC 39 New SEC Filing for Avidity Biosciences Inc. (NASDAQ:RNA) Comment Full text
Relmada Therapeutics Inc. (RLMD) Company Report Aug. 09, 2022, 06:46 UTC 39 Relmada Therapeutics Receives FDA Fast Track Designation for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder Comment Full text
Viracta Therapeutics Inc (VIRX) Company Report Aug. 09, 2022, 05:50 UTC 43 New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX) Comment Full text
Viracta Therapeutics Inc (VIRX) Company Report Aug. 09, 2022, 05:50 UTC 41 New SEC Filing for (CIK:0001061027) Comment Full text